Dive Brief:
- Centene has created two new executive leadership positions to consolidate oversight of its Medicaid, Medicare and Affordable Care Act businesses as the insurer copes with rising costs and looming policy challenges.
- Centene has hired longtime health insurance executive Daniel Finke as its inaugural group president of markets and commercial, the company announced Monday. Centene also named Michael Carson, the CEO of its Medicare business, as group president of Medicare and specialty.
- Both executives will report to Centene CEO Sarah London. Centene did not respond to a request for comment about when the appointments are effective.
Dive Insight:
Centene is the largest insurer in both the Medicaid and ACA markets, with its almost 28 million members heavily concentrated in those businesses. As such, the company is significantly exposed to policy changes in those programs, and is currently working to digest recent policy changes that threaten its finances.
Centene reported a loss of almost $6.7 billion on revenues of almost $195 billion last year, mostly from recording a massive charge to reflect its waning value amid challenging market conditions, including Republican cuts to the healthcare system. Still, the company issued a higher earnings outlook for 2026 than market watchers had expected, betting that it can stabilize elevated medical costs and weather policy turmoil coming out of Washington.
The GOP’s “Big Beautiful Bill” enacted last summer is set to cause millions of individuals to lose Medicaid through new work requirements, stricter eligibility and enrollment processes and lower federal funding. Meanwhile, the ACA marketplaces contracted this year after Congress allowed more generous subsidies for coverage to expire, and efforts by the Trump administration to combat fraud are also expected to boot more individuals off the exchanges.
In a statement, London said the two new executives will be “instrumental” as Centene looks to strengthen its performance.
Finke, who will oversee Centene’s Medicaid and ACA segments, joins Centene from health technology and services company Convey Health Solutions, where he was CEO. Prior to joining Convey in 2024, Finke spent roughly a decade in various leadership roles at CVS and its health insurance division Aetna.
Carson, who has been the chief executive of Centene’s Medicare business Wellcare since 2024, will have expanded oversight of Centene’s MA, prescription drug, dual-eligible and other Medicare businesses as group president of Medicare and specialty, the company announced.
It’s the latest in a flurry of executive appointments from health insurers as the companies contend with regulatory headwinds and rising costs. Elevance beefed up its roster of mid-level executives last week after reshuffling its C-suite earlier this year.
